What is the prevalence of Duchenne muscular dystrophy?
How many people does Duchenne muscular dystrophy affect? Does it have the same prevalence in men and women? And in the different countries?
Duchenne muscular dystrophy (DMD) is a rare genetic disorder primarily affecting males. It is estimated to occur in approximately 1 in every 3,500 to 5,000 male births. DMD is caused by a mutation in the dystrophin gene, leading to progressive muscle weakness and degeneration. Symptoms usually appear in early childhood and worsen over time, resulting in significant disability and reduced life expectancy. While DMD is relatively uncommon, its impact on affected individuals and their families is profound. Early diagnosis and intervention can help manage symptoms and improve quality of life for those living with this condition.
Duchenne muscular dystrophy (DMD) is a rare genetic disorder characterized by progressive muscle degeneration and weakness. It primarily affects males, with an estimated prevalence of 1 in every 3,500 to 5,000 male births. DMD is caused by a mutation in the dystrophin gene, which leads to the absence or deficiency of the dystrophin protein in muscle cells.
The prevalence of DMD varies across different populations and regions. It is considered one of the most common types of muscular dystrophy, affecting individuals worldwide. Although DMD is rare, its impact on affected individuals and their families is significant.
Early diagnosis and intervention are crucial for managing DMD and improving quality of life for those affected. Advances in medical research and therapies have led to improved outcomes and increased life expectancy for individuals with DMD. Ongoing efforts in genetic research and therapeutic development offer hope for future treatments and potential cures for this debilitating condition.
